Skip to main content
. 2021 Oct 21;13(21):5273. doi: 10.3390/cancers13215273

Table 1.

Cancer-relevant genes up- or downregulated in HBE expressers.

Gene Symbol Ratio Function PMID
KRT20 494 Cytokeratin 20, associated with worse prognosis 22493626
CEACAM6 11 Member of the CEA family. Associated with worse prognosis 24186057
CRISP3 10 High expression correlates with malignancy 30609035
ABCC2 10 Multidrug resistance-associated protein 2 26499806
LRRC31 9 Inhibitor of DNA repair 33005030
MUC21 8.5 Associated with incohesive growth of lung cancer 31301084
CEACAM5 8 Member of the CEA family. Driver of breast cancer metastasis 29736411
TRIM72 8 Lower expression predicts recurrence in colon cancer 30852740
PNMT 7.8 Co-amplified with ERBB2 12727839
CXCL17 7 Promotes proliferation and invasion of breast cancer cells 28943434
AMER3 −8.7 Enhances β-catenin signaling in CRC 24251807
KCNC1 −8.8 Its inhibition is associated with poor survival in seminoma 34105734
INSM1 −9.3 In SCLC, low expression associated with better prognosis 32118626
SLIT1 −9 Suppresses breast cancer growth 18829537
RUNDC3A −10.6 High expression correlates with shorter survival in rectal cancer 29050227
HDC −13 Increased expression associated with better survival 31748740
ECEL1 −14 Associated with good prognosis in neuroblastoma 12632073
CHRNA9 −19 High expression associated with poor survival in BRCA 20953833
PCSK1 −23 Reduces growth of breast cancer cells 11241161
NELL1 −27 Down-regulated in kidney cancer 25726761

Top 20 genes showing significantly (p ≤ 0.05 by Student’s t test) higher (10 genes) or lower (10 genes) expression in the 15% upper percentile of B4GALNT2 expression. The red or green color indicates that the change has a putatively cancer-promoting (red) or cancer-restraining (green) effect, according to the literature search. The “PubMed Identification Number” (PMID) of the most relevant paper is indicated.